GE HealthCare (Nasdaq: GEHC) has claimed a European approval for a relatively compact, self-shielded cyclotron designed for the local production of the rapidly decaying isotopes used in PET imaging tracers.
Stryker (NYSE: SYK) earned an FDA 510(k) clearance for its latest ultrasonic bone and soft tissue removal platform, the Sonopet 3.
A team led by Harvard Medical School researchers at Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute has developed a faster way to identify and engineer cancer-fighting therapies.
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, limiting their ability to keep tumors under control.
Thousands of heart patients could be treated without having a metal stent permanently implanted in their arteries—according to research from the University of East Anglia (UEA). A major analysis of more than 7,800 patients found that a newer treatment using drug-coated balloons performed just as well as conventional stents at preventing heart attacks and cardiovascular deaths.
Heart failure (HF) is a condition in which the heart is not able to pump blood effectively. However, its effects go beyond pumping and circulation. HF is also known to cause a lasting form of innate immune memory in stem cells that synthesize blood and progenitor cells that are present in the bone marrow (BM). This can result in the production of immune cells that promote inflammation and worsen heart function. However, the exact mechanism of this process remained unclear.
One of the main ways that the APOE4 gene variant, the biggest genetic risk factor for late-onset Alzheimer’s disease, undermines brain circuit function is by disrupting the process of insulating neurons with a fatty sheath that optimizes their electrical transmission.
One of the great challenges in treating diseases like amyotrophic lateral sclerosis (ALS) is not necessarily finding a promising drug. It is getting the drug to the right place.
Researchers have uncovered a previously overlooked immune cell that can recognize and kill small cell lung cancer, the most aggressive form of the disease globally. Published in Cancer Cell, the WEHI study found patients with higher levels of these cells lived longer, uncovering a hidden immune defense that could be exploited to attack these hard-to-treat tumors.
A research team from the Faculty of Dentistry at The University of Hong Kong (HKU), working in collaboration with Su Ryon Shin’s group at Brigham and Women’s Hospital, Harvard Medical School, has advanced and preclinically validated a shape-adaptive hydrogel designed for challenging clinical trauma scenarios involving severe bleeding, irregular bone defects and comminuted fractures.